Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity.
Venugopalan V, Casaus D, Kainz L, Slaton CN, Hurst N, Bruzzone M, Hu C, Sword G, Cherabuddi K, Iovine N, Liu J, Scheetz MH, Rhodes N, Maranchick N, Peloquin CA, Klinker K, Alshaer MH.
Venugopalan V, et al.
Pharmacotherapy. 2023 Jan;43(1):6-14. doi: 10.1002/phar.2744. Epub 2022 Dec 2.
Pharmacotherapy. 2023.
PMID: 36401796